← Back to Search

MRI-Guided Heart Catheterization for Cardiac Conditions

N/A
Waitlist Available
Led By Joshua Kanter, MD
Research Sponsored by Joshua Kanter
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing a medically necessary cardiovascular catheterization
Must not have
Cardiovascular instability including hemodynamic instability (such as requiring significant vasoactive infusion support) or mechanical hemodynamic support
Women who are pregnant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study, 5 years.
Awards & highlights
No Placebo-Only Group

Summary

This trial will use MRI to guide catheters during heart procedures instead of x-ray, which doesn't expose patients to radiation.

Who is the study for?
This trial is for individuals needing heart catheterization, which isn't an emergency. It's not for pregnant or nursing women (unless they can discard breast milk for a day), people with unstable heart conditions, or those who have certain metal implants/devices that make MRI scans unsafe.
What is being tested?
The study is testing a new way to do heart catheterizations using MRI instead of X-rays. This method aims to guide the catheters without exposing patients to radiation, potentially making the procedure safer.
What are the potential side effects?
Since this trial uses MRI technology instead of radiation, there are no radiation-related side effects. However, some may experience discomfort from lying still during the MRI or reactions related to standard risks of catheterization.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a heart-related catheter procedure.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not need drugs or machines to help my heart and circulation function.
Select...
I am currently pregnant.
Select...
My kidney function is severely reduced.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study, 5 years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study, 5 years. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Test the feasibility of navigating catheters into right heart structures using real-time MRI
Secondary study objectives
Measurement of radiation exposure
Number of participants whose MRI cardiac catheterization procedure was prematurely terminated

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MRI guided cardiac catheterizationExperimental Treatment2 Interventions
Magnetic resonance imaging will be used to guide cardiac catheterization procedures.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Magnetic resonance imaging
2016
Completed Phase 3
~1240

Find a Location

Who is running the clinical trial?

Joshua KanterLead Sponsor
1 Previous Clinical Trials
27 Total Patients Enrolled
Joshua Kanter, MDPrincipal Investigator - Children's National Research Institute
Children's National Research Institute
2 Previous Clinical Trials
109 Total Patients Enrolled

Media Library

MRI guided cardiac catheterization Clinical Trial Eligibility Overview. Trial Name: NCT02739087 — N/A
Patent Ductus Arteriosus Research Study Groups: MRI guided cardiac catheterization
Patent Ductus Arteriosus Clinical Trial 2023: MRI guided cardiac catheterization Highlights & Side Effects. Trial Name: NCT02739087 — N/A
MRI guided cardiac catheterization 2023 Treatment Timeline for Medical Study. Trial Name: NCT02739087 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top